Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 12, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aldeyra Therapeutics, Inc.
| -183.24K |
$3.17 | -$580,759.68 | -11.07% | 1.47M |
Mar 9 - Mar 12
| |||||||
Aldeyra Therapeutics, Inc.
| 199.25K |
$3.89 | -$382,158.52 | +13.69% | 1.65M |
Sep 7
| |||||||
Evoke Pharma Inc
|
0
|
—
|
—
|
—
|
0
|
May 10
| |||||||
F-Star Therapeutics, Inc.
| -15.00K |
$7.12 | -$106,828.48 | -100.00% |
0
|
Nov 20 - Mar 8
| |||||||
Aldeyra Therapeutics, Inc.
| 238.75K |
—
|
—
| +19.63% | 1.46M |
Feb 28
| |||||||
Aldeyra Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 15
| |||||||
Aldeyra Therapeutics, Inc.
| 17.7K |
$3.36 | $59,546.34 | +1.48% | 1.22M |
Jun 23
| |||||||
F-Star Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Evoke Pharma Inc
|
0
|
—
|
—
|
—
|
0
|
Apr 27
| |||||||
Aldeyra Therapeutics, Inc.
| 250K |
—
|
—
| +26.35% | 1.2M |
Mar 30
| |||||||
Evoke Pharma Inc
|
0
|
—
|
—
|
—
|
0
|
May 5
| |||||||
F-Star Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 4
| |||||||
Aldeyra Therapeutics, Inc.
| 46.62K |
—
|
—
| +5.17% | 948.84K |
Apr 12
| |||||||
F-Star Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 19
| |||||||
Spring Bank Pharmaceuticals, Inc.
| 9.23K |
—
|
—
| +18.19% | 60.02K |
Sep 30
| |||||||
Spring Bank Pharmaceuticals, Inc.
| 8.42K |
—
|
—
| +19.87% | 50.78K |
Jun 30
| |||||||
Spring Bank Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 24
| |||||||
Avidity Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Evoke Pharma Inc
|
0
|
—
|
—
|
—
|
0
|
May 27
| |||||||
Spring Bank Pharmaceuticals, Inc.
| 13.31K |
—
|
—
| +45.79% | 42.36K |
Mar 31
| |||||||
Aldeyra Therapeutics, Inc.
| 250K |
—
|
—
| +38.33% | 902.22K |
Mar 2
| |||||||
Spring Bank Pharmaceuticals, Inc.
| 7.83K |
—
|
—
| +36.90% | 29.06K |
Dec 31
| |||||||
Aldeyra Therapeutics, Inc.
| 20K |
$5.10 | $101,908.00 | +3.16% | 652.22K |
Dec 16
| |||||||
Aldeyra Therapeutics, Inc.
| 8.71K |
$5.68 | $49,483.25 | +1.40% | 632.22K |
Sep 30
|
Scheduled
| ||||||
Spring Bank Pharmaceuticals, Inc.
| 3.6K |
—
|
—
| +20.41% | 21.23K |
Sep 30
| |||||||
Aldeyra Therapeutics, Inc.
| 8.68K |
$5.81 | $50,432.54 | +1.41% | 623.51K |
Sep 23
|
Scheduled
| ||||||
Aldeyra Therapeutics, Inc.
| 14.29K |
$5.91 | $84,464.94 | +2.38% | 614.83K |
Sep 18
| |||||||
Aldeyra Therapeutics, Inc.
| 21.55K |
$5.91 | $127,448.68 | +3.72% | 600.54K |
Sep 13 - Sep 16
| |||||||
Aldeyra Therapeutics, Inc.
| 13K |
$5.85 | $75,990.00 | +2.25% | 591.99K |
Sep 13 - Sep 16
| |||||||
Aldeyra Therapeutics, Inc.
| 20K |
$5.14 | $102,824.00 | +3.58% | 578.99K |
Sep 9 - Sep 10
| |||||||
Spring Bank Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 10
| |||||||
Spring Bank Pharmaceuticals, Inc.
| 3.35K |
—
|
—
| +23.50% | 17.63K |
Jun 28
| |||||||
Evoke Pharma Inc
|
0
|
—
|
—
|
—
|
0
|
May 2
| |||||||
Spring Bank Pharmaceuticals, Inc.
| 1.18K |
—
|
—
| +9.01% | 14.27K |
Mar 29
| |||||||
Aldeyra Therapeutics, Inc.
| 250K |
—
|
—
| +81.68% | 556.05K |
Mar 5
| |||||||
Spring Bank Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Evoke Pharma Inc
|
0
|
—
|
—
|
—
|
0
|
Apr 26
| |||||||
Aldeyra Therapeutics, Inc.
| 101.27K |
—
|
—
| +50.33% | 302.48K |
Mar 6
| |||||||
Spring Bank Pharmaceuticals, Inc.
| 852 |
—
|
—
| +6.96% | 13.09K |
Jan 2
| |||||||
Oncobiologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 26
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.